GN Store Nord
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 14
Tags Tree
Selected: 0
No matching results found.
- Does the undertaking identify any material prior period errors as outlined in ESRS 1, section 7.5, regarding reporting errors in prior periods, and if so, what disclosures are provided in relation to these errors?
-
Question Id: E1-1_01
GHG emissions in 2021 have been restated across all scopes because of adjustments, improvements in data quality, methodological changes and updates to emission factors (see table to the right). Restatements are compared to 2023, which included SteelSeries emissions. SteelSeries emissions from 2021, before the acquisition, were therefore already captured in the data. The baseline for our Scope 1 and 2 emission reduction target has been restated from 10,507 tCO2eq to 9,832 tCO2eq, a decrease of 6.4%.
Report Date: 4Q2024Relevance: 85%
- Provide a detailed disclosure of biogenic emissions of CO2 resulting from the combustion or biodegradation of biomass, ensuring these are reported separately from Scope 2 GHG emissions. Include emissions of other greenhouse gases, specifically CH4 and N2O, within this disclosure. If the emission factors utilized do not distinctly identify the percentage of biomass or biogenic CO2, disclose this information. Additionally, if emissions of GHGs other than CO2, particularly CH4 and N2O, are unavailable or excluded from location-based grid average emissions factors or the market-based method, disclose this information accordingly.
-
Question Id: E1-6_24
Biogenic CO2 emissions in Scope 1 are reported as 0.13. Biogenic emissions in the value chain are reported as -4,780.
Report Date: 4Q2024Relevance: 10%